Stent Selection and Antiplatelet Therapy Duration One Size Does Not Fit All

被引：1

作者：

Kandzari, David E. ^{[1
]}

机构：

[1] Piedmont Heart Inst, Atlanta, GA 30309 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 08期

关键词：

drug-eluting stent(s); stent(s); thrombosis; zotarolimus; ZOTAROLIMUS-ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; BARE-METAL STENTS; 5-YEAR FOLLOW-UP; CLINICAL-OUTCOMES; THROMBOSIS; TRIAL; IMPLANTATION; ASSOCIATION; PREDICTORS;

D O I：

10.1016/j.jacc.2014.11.055

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：816 / 819

页数：4

共 26 条

[1]

Camenzind E., 2014, EUR SOC CARD C SEPT

[2] Bare metal stent restenosis is not a benign clinical entity [J].

Chen, Michael S. ;

John, Jim M. ;

Chew, Derek P. ;

Lee, David S. ;

Ellis, Stephen G. ;

Bhatt, Deepak L. .

AMERICAN HEART JOURNAL, 2006, 151 (06) :1260-1264

[3]

ClinicalTrials.gov, 2013, GLOB LEAD CLIN STUD

[4]

ClinicalTrials.gov, 2009, DUAL ANT THER STUD D

[5] Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation [J].

Eisenstein, Eric L. ;

Anstrom, Kevin J. ;

Kong, David F. ;

Shaw, Linda K. ;

Tuttle, Robert H. ;

Mark, Daniel B. ;

Kramer, Judith M. ;

Harrington, Robert A. ;

Matchar, David B. ;

Kandzari, David E. ;

Peterson, Eric D. ;

Schulman, Kevin A. ;

Califf, Robert M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (02) :159-168

[6] Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents The OPTIMIZE Randomized Trial [J].

Feres, Fausto ;

Costa, Ricardo A. ;

Abizaid, Alexandre ;

Leon, Martin B. ;

Marin-Neto, J. Antonio ;

Botelho, Roberto V. ;

King, Spencer B., III ;

Negoita, Manuela ;

Liu, Minglei ;

de Paula, J. Eduardo T. ;

Mangione, Jose A. ;

Meireles, George X. ;

Castello, Helio J., Jr. ;

Nicolela, Eduardo L., Jr. ;

Perin, Marco A. ;

Devito, Fernando S. ;

Labrunie, Andre ;

Salvadori, Decio, Jr. ;

Gusmao, Marcos ;

Staico, Rodolfo ;

Costa, J. Ribamar ;

de Castro, Juliana P. ;

Abizaid, Andrea S. ;

Bhatt, Deepak L. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (23) :2510-2522

[7] Optical Coherence Tomography Assessment of In Vivo Vascular Response After Implantation of Overlapping Bare-Metal and Drug-Eluting Stents [J].

Guagliumi, Giulio ;

Musumeci, Giuseppe ;

Sirbu, Vasile ;

Bezerra, Hiram G. ;

Suzuki, Nobuaki ;

Fiocca, Luigi ;

Matiashvili, Aleksandre ;

Lortkipanidze, Nikoloz ;

Trivisonno, Antonio ;

Valsecchi, Orazio ;

Biondi-Zoccai, Giuseppe ;

Costa, Marco A. .

JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (05) :531-539

[8] Risk of Major Adverse Cardiac Events Following Noncardiac Surgery in Patients With Coronary Stents [J].

Hawn, Mary T. ;

Graham, Laura A. ;

Richman, Joshua S. ;

Itani, Kamal M. F. ;

Henderson, William G. ;

Maddox, Thomas M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (14) :1462-1472

[9] Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents [J].

Iakovou, I ;

Schmidt, T ;

Bonizzoni, E ;

Ge, L ;

Sangiorgi, GM ;

Stankovic, G ;

Airoldi, F ;

Chieffo, A ;

Montorfano, M ;

Carlino, M ;

Michev, I ;

Corvaja, N ;

Briguori, C ;

Gerckens, U ;

Grube, E ;

Colombo, A .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17) :2126-2130

[10] Final 5-Year Outcomes From the Endeavor Zotarolimus-Eluting Stent Clinical Trial Program [J].

Kandzari, David E. ;

Leon, Martin B. ;

Meredith, Ian ;

Fajadet, Jean ;

Wijns, William ;

Mauri, Laura .

JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (05) :504-512

← 1 2 3 →